EXACT Therapeutics AS (OSL:EXTX)
Norway · Delayed Price · Currency is NOK 1.750
-0.120 (-6.42%)
At close: Jan 27, 2026
EXACT Therapeutics AS Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
12
Market Cap
120.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 4.46K | -450.06K | -99.02% |
| Dec 31, 2022 | 454.52K | 402.52K | 774.07% |
| Dec 31, 2021 | 52.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 109.99M |
| Aqua Bio Technology ASA | 101.51M |
| Nykode Therapeutics AS | 73.37M |
| Arctic Bioscience AS | 45.90M |
| SoftOx Solutions AS | 13.59M |
| PCI Biotech Holding ASA | 4.69M |
| Lytix Biopharma AS | 377.00K |
| Circio Holding ASA | 123.00K |